QUOTE AND NEWS
StreetInsider.com  Apr 7  Comment 
The following is a list of notable articles to help get you through the lunch hour: Microsoft Corp (MSFT) Looks to Bolster Xbox Appeal with New TV Content -> Read this! Kroger (KR) Price Target Raised to $50 at Deutsche Bank -> Read...
DailyFinance  Mar 31  Comment 
SAN FRANCISCO, CA -- (Marketwired) -- 03/31/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced the appointment of Rick Bierly as chief financial officer, effective March 31, 2014. Rick will serve as Medivation's principal financial and...
DailyFinance  Mar 31  Comment 
FORT WASHINGTON, PA--(Marketwired - March 31, 2014) - The National Comprehensive Cancer Network® ( NCCN®) Oncology Research Program ( ORP) has been awarded a $2.2-million grant from Astellas Pharma, Inc. and Medivation, Inc. to...
StreetInsider.com  Mar 24  Comment 
Arlington Asset Investment Corp. (NYSE: AI) 3.4% LOWER; announced that it has commenced an underwritten registered public offering of 2,750,000 shares of Class A common stock. The Company also expects to grant the underwriters an option for 30...
StreetInsider.com  Mar 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Astellas+Pharma+Receuves+Marketing+Approval+for++XTANDI+in+Japan+%28MDVN%29/9310630.html for the full story.
FiercePharma  Mar 19  Comment 
Astellas and Medivation today said they are asking the FDA for approval for Xtandi to be used on patients with metastatic castration-resistant prostate cancer who have not received chemotherapy.
DailyFinance  Mar 18  Comment 
TOKYO, JAPAN and SAN FRANCISCO, CA -- (Marketwired) -- 03/18/14 -- Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug...
Benzinga  Mar 12  Comment 
Short interest in most of the leading biotech and emerging pharmaceutical companies declined between the February 14 and February 28 settlement dates. But Biogen Idec (NASDAQ: BIIB), BioMarin Pharmaceutical (NASDAQ: BMRN) and Medivation (NASDAQ:...
TheStreet.com  Feb 28  Comment 
NEW YORK (TheStreet) -- Medivation  was falling 14.12% to $72.59 on Friday after the biopharmaceutical company forecast guidance that came up well short of analysts' expectations. Medivation announced in its fourth-quarter earnings report that...
StreetInsider.com  Feb 28  Comment 
The following is a list of notable articles to help get you through the lunch hour: Rockwood (ROC) Stock Pressured: Huntsman (HUN) Sees EU Proceeding with Investigation into Deal (Earlier) -> Read this! Restaurant Order Platform GrubHub (GRUB)...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki